Skip to main content

Table 1 Characteristics of adult subjects with COPD from the UK Biobank

From: Muscle loss phenotype in COPD is associated with adverse outcomes in the UK Biobank

 

No MLP criteria

(N = 25,981)

MLP criteria

(N = 29,801)

Standardized difference (%)

 

Factor

N

Statistics

N

Statistics

p-value

Sex

25,981

 

29,801

 

24.72

< 0.001c

 Female

 

13,163 (50.7)

 

11,464 (38.5)

  

 Male

 

12,818 (49.3)

 

18,337 (61.5)

  

Age at recruitment (years)

25,981

57.6 ± 7.8

29,801

60.5 ± 6.9

38.71

< 0.001a2

Ethnicity

25,981

 

29,801

 

0

< 0.001c

 British

 

24,446 (94.1)

 

28,057 (94.1)

  

 Irish

 

653 (2.5)

 

899 (3.0)

  

 Any other white background

 

882 (3.4)

 

845 (2.8)

  

Body mass index (BMI) (Kg/m2)

25,981

28.2 ± 4.4

29,743

25.3 ± 4.2

-67.3

< 0.001a2

FEV1, percent predicted

25,981

79.7 ± 17.8

29,801

78.7 ± 19.1

-5.5

< 0.001a2

FEV1, GOLD stage

25,981

 

29,801

 

8.43

< 0.001c

 > 80% (mild)

 

13,298 (51.2)

 

14,842 (49.8)

  

 50–79% (moderate)

 

11,242 (43.3)

 

12,653 (42.5)

  

 30–49% (severe)

 

1,266 (4.9)

 

1,978 (6.6)

  

 < 30% (very severe)

 

175 (0.67)

 

328 (1.1)

  

FEV1, liters

25,981

2.4 ± 0.74

29,801

2.4 ± 0.79

-4

< 0.001a2

FEV1/FVC ratio

25,981

0.65 ± 0.06

29,801

0.64 ± 0.07

-14.8

< 0.001a2

Alcohol drinker status

25,961

 

29,758

 

5.45

< 0.001c

 Never

 

699 (2.7)

 

981 (3.3)

 

< 0.001d

 Previous

 

892 (3.4)

 

1,292 (4.3)

 

< 0.001d

 Current

 

24,370 (93.9)

 

27,485 (92.4)

 

 < 0.001d

Smoking status

25,871

 

29,656

 

7.66

< 0.001c

 Never

 

10,686 (41.3)

 

11,981 (40.4)

 

0.0264d

 Previous

 

10,732 (41.5)

 

11,460 (38.6)

 

< 0.001d

 Current

 

4,453 (17.2)

 

6,215 (21.0)

 

 < 0.001d

Pack years of smoking (years)

11,418

25.5 [14.0, 39.4]

13,407

27.5 [14.8, 42.0]

8.06

< 0.001b

Ever addicted to any substance or behavior

7,782

622 (8.0)

8,203

612 (7.5)

-2

0.21c

History of cancer diagnosis

25,891

2,001 (7.7)

29,698

2,754 (9.3)

5.54

< 0.001c

Doctor diagnosed emphysema

6,010

56 (0.93)

6,425

101 (1.6)

5.76

0.001c

Age emphysema diagnosed by doctor

56

54.4 ± 13.1

101

58.7 ± 11.1

35.23

0.032a1

IPAQ activity group

21,263

 

23,966

 

8.39

< 0.001c

 Low

 

3,698 (17.4)

 

4,539 (18.9)

  

 Moderate

 

8,379 (39.4)

 

9,745 (40.7)

  

 High

 

9,186 (43.2)

 

9,682 (40.4)

  

Summed minutes activity (minutes)

21,263

105.0 [60.0, 180.0]

23,966

100.0 [50.0, 180.0]

-6.5

< 0.001b

MET minutes per week for walking (minutes/week)

21,263

693.0 [330.0, 1386.0]

23,966

693.0 [330.0, 1386.0]

-1.5

0.12b

  1. Statistics presented as Mean ± SD, Median [P25, P75], N (column %)
  2. MLP criteria were defined as meeting at least one of the four MLP definitions
  3. MET metabolic equivalent of task, IPAQ International Physical Activity Questionnaire, MLP muscle loss phenotype
  4. p-values:
  5. a1t-test
  6. a2Satterthwaite t test
  7. bWilcoxon Rank Sum test
  8. cPearson's chi-square test
  9. dFisher's Exact test